Skip to main content
. 2021 Sep 16;11(9):e050344. doi: 10.1136/bmjopen-2021-050344

Table 2.

Comparison of the descriptive results from FORTA, PRISCUS and EU(7)-PIM list

FORTA PIM PRISCUS PIM EU(7)-PIM
Medication
 Total number (%) of drugs used 24 535 24 535 24 535
  Prescribed 18 600 (75.8) 18 600 (75.8) 18 600 (75.8)
  OTC 5935 (24.2) 5935 (24.2) 5935 (24.2)
 Total number (%) of PIM 2852 (11.6) 963 (3.9) 4311 (17.6)
  Prescribed 2474 (86.7) 939 (97.5) 3919 (90.9)
  OTC 378 (13.3) 24 (2.5) 392 (9.1)
Median number of PIM (range) 1 (0–7) 0 (0–4) 1 (0–8)
Mean number of PIM (SD) 0.9 (±1.0) 0.3 (±0.6) 1.4 (±1.3)
Patients (%)
 Patients with at least one PIM 55.9 24.7 70.1
 Patients with one PIM 1048 (32.9) 656 (20.6) 1020 (32.0)
 Patients with two PIMs 496 (15.6) 123 (3.9) 678 (21.3)
 Patients with three PIMs 168 (5.3) 15 (0.5) 320 (10.0)
 Patients with four PIMs 47 (1.5) 4 (0.1) 140 (4.4)
 Patients with five PIMs 19 (0.6) 50 (1.6)
 Patients with six PIMs 3 (0.1) 19 (0.6)
 Patients with seven PIMs 1 (0.03) 5 (0.2)
 Patients with eight PIMs 2 (0.1)

FORTA, Fit fOR The Aged; OTC, over-the-counter; PIM, potentially inappropriate medication.